Zobrazeno 1 - 10
of 20
pro vyhledávání: '"X. Melody Qu"'
Autor:
Sondos Zayed, MD, X. Melody Qu, MD, Andrew Warner, MSc, Tina Wanting Zhang, MD, Joanna M. Laba, MD, George B. Rodrigues, MD, PhD, David A. Palma, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 325-332 (2020)
Purpose: We examined whether female authorship, traditionally underrepresented in the radiation oncology (RO) literature, has improved during the past decade, and whether the introduction of double-blind peer review (where reviewers are blinded to au
Externí odkaz:
https://doaj.org/article/5f6fc26abede4588ac04c3c435ccaf28
Autor:
David A. Palma, Hanbo Chen, Houda Bahig, Stewart Gaede, Stephen Harrow, Joanna M. Laba, X. Melody Qu, George B. Rodrigues, Brian P. Yaremko, Edward Yu, Alexander V. Louie, Inderdeep Dhaliwal, Christopher J. Ryerson
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-17 (2019)
Abstract Background Stereotactic ablative radiotherapy (SABR) has become an established treatment option for medically-inoperable early-stage (Stage I-IIA) non-small cell lung cancer (ES-NSCLC). SABR is able to obtain high rates of local control with
Externí odkaz:
https://doaj.org/article/9e2d916f092b4b5eb2f0df255c4e4e56
Autor:
Stephen Harrow, David A. Palma, Robert Olson, Stewart Gaede, Alexander V. Louie, Cornelis Haasbeek, Liam Mulroy, Michael Lock, George B. Rodrigues, Brian P. Yaremko, Devin Schellenberg, Belal Ahmad, Sashendra Senthi, Anand Swaminath, Neil Kopek, Mitchell Liu, Roel Schlijper, Glenn S. Bauman, Joanna Laba, X. Melody Qu, Andrew Warner, Suresh Senan
Publikováno v:
International journal of radiation oncology, biology, physics. Elsevier Inc.
International Journal of Radiation Oncology Biology Physics. Elsevier Inc.
Harrow, S, Palma, D A, Olson, R, Gaede, S, Louie, A V, Haasbeek, C, Mulroy, L, Lock, M, Rodrigues, G B, Yaremko, B P, Schellenberg, D, Ahmad, B, Senthi, S, Swaminath, A, Kopek, N, Liu, M, Schlijper, R, Bauman, G S, Laba, J, Qu, X M, Warner, A & Senan, S 2022, ' Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) : Extended Long-Term Outcomes ', International Journal of Radiation Oncology Biology Physics, vol. 114, no. 4, pp. 611-616 . https://doi.org/10.1016/j.ijrobp.2022.05.004, https://doi.org/10.1016/j.ijrobp.2022.05.004
International Journal of Radiation Oncology Biology Physics, 114(4), 611-616. Elsevier Inc.
International Journal of Radiation Oncology Biology Physics. Elsevier Inc.
Harrow, S, Palma, D A, Olson, R, Gaede, S, Louie, A V, Haasbeek, C, Mulroy, L, Lock, M, Rodrigues, G B, Yaremko, B P, Schellenberg, D, Ahmad, B, Senthi, S, Swaminath, A, Kopek, N, Liu, M, Schlijper, R, Bauman, G S, Laba, J, Qu, X M, Warner, A & Senan, S 2022, ' Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) : Extended Long-Term Outcomes ', International Journal of Radiation Oncology Biology Physics, vol. 114, no. 4, pp. 611-616 . https://doi.org/10.1016/j.ijrobp.2022.05.004, https://doi.org/10.1016/j.ijrobp.2022.05.004
International Journal of Radiation Oncology Biology Physics, 114(4), 611-616. Elsevier Inc.
Purpose: Long-term randomized data assessing the effect of ablative therapies in patients with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastases (SABR-COMET) randomized phase 2 tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d17ce9ad8434aab2a3c2c8f33b78d70
https://research.vumc.nl/en/publications/c7d100f6-f01f-4675-b566-a119e14713b2
https://research.vumc.nl/en/publications/c7d100f6-f01f-4675-b566-a119e14713b2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joanna Laba, David A. Palma, Esther J. Nossent, George Rodrigues, Suresh Senan, Christopher J. Ryerson, Inderdeep Dhaliwal, X. Melody Qu, Suzan F M Nijman, Christopher D. Goodman
Publikováno v:
International Association for the Study of Lung Cancer Advanced Radiation Technology Committee 2020, ' A Primer on Interstitial Lung Disease and Thoracic Radiation ', Journal of Thoracic Oncology, vol. 15, no. 6, pp. 902-913 . https://doi.org/10.1016/j.jtho.2020.02.005
Interstitial lung disease (ILD) is a term used to describe a heterogeneous group of lung disorders with characteristic clinical and imaging features. Patients with ILD are at an increased risk of developing NSCLC, which is frequently medically comorb
Autor:
Sashendra Senthi, Suresh Senan, Alexander V. Louie, Mitchell Liu, X. Melody Qu, Stewart Gaede, Liam Mulroy, Ava John-Baptiste, Neil Kopek, Yujie Chen, George Rodrigues, David A. Palma, Andrew Warner, Gregory S. Zaric, Robert Olson, Anand Swaminath, Devin Schellenberg, Stephen Harrow
Publikováno v:
Qu, X M, Chen, Y, Zaric, G S, Senan, S, Olson, R A, Harrow, S, John-Baptiste, A, Gaede, S, Mulroy, L A, Schellenberg, D, Senthi, S, Swaminath, A, Kopek, N, Liu, M, Warner, A, Rodrigues, G B, Palma, D A & Louie, A V 2021, ' Is SABR cost-effective in oligometastatic cancer? An economic analysis of the SABR-COMET randomized trial ', International journal of radiation oncology, biology, physics, vol. 109, no. 5, pp. 1176-1184 . https://doi.org/10.1016/j.ijrobp.2020.12.001
International journal of radiation oncology, biology, physics, 109(5), 1176-1184. Elsevier Inc.
International journal of radiation oncology, biology, physics, 109(5), 1176-1184. Elsevier Inc.
Purpose The phase 2 randomized study SABR-COMET demonstrated that in patients with controlled primary tumors and 1 to 5 oligometastatic lesions, SABR was associated with improved progression-free survival (PFS) compared with standard of care (SoC), b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d1ca51780663aeca6827c5a6168cfd3
https://research.vumc.nl/en/publications/c7ecc091-f39a-4ddf-9dca-24bc111c96ce
https://research.vumc.nl/en/publications/c7ecc091-f39a-4ddf-9dca-24bc111c96ce
Autor:
X. Melody Qu, Belal Ahmad, Stewart Gaede, Roel Schlijper, Sashendra Senthi, Mitchell Liu, Michael Lock, Glenn Bauman, Robert Olson, Anand Swaminath, Liam Mulroy, George Rodrigues, Devin Schellenberg, Stephen Harrow, Brian Yaremko, Alexander V. Louie, Andrew Warner, Joanna Laba, Neil Kopek, David A. Palma, Cornelis J.A. Haasbeek, Suresh Senan, S. Currie, Karen Moore
Publikováno v:
Journal of Clinical Oncology, 38(25), 2830-2838. American Society of Clinical Oncology
Journal of Clinical Oncology
Palma, D A, Olson, R, Harrow, S, Gaede, S, Louie, A V, Haasbeek, C, Mulroy, L, Lock, M, Rodrigues, G B, Yaremko, B P, Schellenberg, D, Ahmad, B, Senthi, S, Swaminath, A, Kopek, N, Liu, M, Moore, K, Currie, S, Schlijper, R, Bauman, G S, Laba, J, Qu, X M, Warner, A & Senan, S 2020, ' Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers : Long-term results of the SABR-COMET Phase II randomized trial ', Journal of Clinical Oncology, vol. 38, no. 25, pp. 2830-2838 . https://doi.org/10.1200/JCO.20.00818
Journal of Clinical Oncology
Palma, D A, Olson, R, Harrow, S, Gaede, S, Louie, A V, Haasbeek, C, Mulroy, L, Lock, M, Rodrigues, G B, Yaremko, B P, Schellenberg, D, Ahmad, B, Senthi, S, Swaminath, A, Kopek, N, Liu, M, Moore, K, Currie, S, Schlijper, R, Bauman, G S, Laba, J, Qu, X M, Warner, A & Senan, S 2020, ' Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers : Long-term results of the SABR-COMET Phase II randomized trial ', Journal of Clinical Oncology, vol. 38, no. 25, pp. 2830-2838 . https://doi.org/10.1200/JCO.20.00818
PurposeThe oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However, long-term randomized data testing this paradigm a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e07c03a4d04b5151af53c561a41f12
https://research.vumc.nl/en/publications/d4d3c2fe-12be-446a-8b27-a96e4ec46504
https://research.vumc.nl/en/publications/d4d3c2fe-12be-446a-8b27-a96e4ec46504
Autor:
Houda Bahig, David A. Palma, Stephen Harrow, Stewart Gaede, Hanbo Chen, Edward Yu, Joanna Laba, George Rodrigues, Alexander V. Louie, X. Melody Qu, Christopher J. Ryerson, Inderdeep Dhaliwal, Brian Yaremko
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-17 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-17 (2019)
Background Stereotactic ablative radiotherapy (SABR) has become an established treatment option for medically-inoperable early-stage (Stage I-IIA) non-small cell lung cancer (ES-NSCLC). SABR is able to obtain high rates of local control with low rate
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 12(4)
Introduction: The ability to predict lymph node (LN) status is essential in the management of men with localized squamous cell carcinoma (SCC) of the penis. There has been limited external validation of available risk stratification tools, particular